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ABSTRACT 
Introduction: Cholestatic liver dysfunction frequently occurs during critical illness. 
Administration of parenteral nutrition (PN) is thought to aggravate this. Underlying 
mechanisms are not clear. 
Methods: In a burn model of prolonged critical illness, rabbits were randomized to a 
nutritional strategy either accepting caloric deficits (Fasted, n=11) or covering caloric needs 
by PN (Fed, n=10). At baseline and after 7 days of critical illness, markers of hepatotoxicity, 
circulating bile acids and the hepatobiliary transport system were studied. 
Results: Fasted animals had lower circulating ALT/AST levels than fed animals at day 7. 
Compared to baseline values, fed animals displayed lower serum unconjugated cholic acid 
(CA) and deoxycholic acid (DCA) levels. Unconjugated DCA remained unaltered in fasted 
animals. Unconjugated lithocholic acid (LCA) was increased comparably in all animals, 
whereas hyodeoxycholic acid (HDCA) was not altered. In contrast, fasting induced a shift 
from unconjugated CA and DCA to glyco-CA and glyco-DCA. Total bile acids did not 
correlate with the bile acid producing enzyme CYP7A1, but with the basolateral efflux 
transporter MRP3. Fasting increased protein expression of the basolateral (MRP3) and the 
canalicular (BSEP) transporter, whereas the canalicular efflux pump MRP2 was suppressed. 
Gene expression levels of the nuclear receptor FXR were lower with fasting and correlated 
inversely with MRP3. The heterodimer partner of FXR, RXRA, was increased with fasting 
and correlated positively with MRP3.  
Conclusion: During prolonged critical illness, withholding PN improved markers for 
hepatocyte injury and accentuated bile acid transport towards the blood. This suggests that the 
latter is an adaptive rather than a dysfunctional feedback to illness. 
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Introduction 
Cholestatic liver dysfunction frequently occurs during critical illness and is associated with 
poor outcome [1-3]. However, critical illness-related cholestatic liver dysfunction is not yet 
well characterized and even a clear definition of cholestasis during critical illness is still 
lacking. Previous work by us and others has indicated that an altered function of the hepatic 
bile acid transporters may be involved in the pathogenesis of this condition [3-7]. In liver 
biopsies of critically ill patients, we could demonstrate that the apical bile acid (salt) export 
pump BSEP was downregulated, whereas the basolateral efflux pumps MRP3 and MRP4, 
which reflux bile acids back to the circulation, were strongly upregulated. This reversal of bile 
acid transport to the blood was in line with increased circulating conjugated bile acids and 
correlated strongly with histopathological markers of bilirubinostasis and ductular reaction 
[6]. 
Critical illness is often accompanied by anorexia and a failing of gastro-intestinal function. To 
prevent caloric deficits, when enteral nutrition is insufficient or poorly tolerated, 
administration of parenteral nutrition (PN) has been recommended, commencing as early as 
the first week of critical illness. PN is claimed to play a role in the development of cholestatic 
liver dysfunction [8] and the mechanisms behind PN-induced cholestasis may include 
alterations in bile composition and transport as well as direct toxicity by bile acids to the 
hepatocytes. 
In this study we aimed to investigate whether fasting, by withholding PN, limits cholestatic 
liver dysfunction in a rabbit model of prolonged critical illness. We compared the impact of 
fasting with PN-feeding during the first week of critical illness on serum levels of ALT, AST 
and bile acids and correlated these findings with the expression profiles of hepatobiliary 
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transporters and nuclear receptors involved in the regulation of transport and metabolism of 
bile acids and bilirubin. 
 
Materials and methods 
Experimental study design: The study was performed in a validated rabbit model of prolonged 
critical illness that comprised the combination of a reproducible third degree burn injury and 
central vascular access. This model closely mimics the clinical, metabolic and endocrine 
abnormalities of critically ill patients [9-11]. The model has been described in detail 
previously [9-11]. In brief, 3-month-old male New Zealand White rabbits were anesthetized 
and catheters (for blood sampling, intravenous nutrition and insulin administration) were 
placed under general anesthesia and a full thickness burn injury equaling 15–20% of the total 
body surface area was inflicted on the flanks after performing a paravertebral block. Next, 
animals were transferred to individual cages and fluid resuscitation was started with 
Hartmann solution (Baxter, Lessiness, Belgium) supplemented with 5% glucose (16 mL/h). 
Blood glucose levels were kept normoglycemic (targeted below 110 mg/dL) with insulin 
infusion. The animals were deprived from oral feeding but had free access to water and a 
small amount of hay. On day 1, rabbits were allocated to a fed group receiving a balanced 
mixed-component parenteral nutrition (84% glucose, 11% protein and 5% lipids) for 6 days 
(280 kCal/day) or a fasted group that only received dextrose 1.4% with 0.03% NaCl (14 
kCal/day). On day 7, animals were sacrificed and samples were taken from liver and snap-
frozen in liquid nitrogen. The energy content and composition of the parenteral nutrition is 
well within the physiological requirement for healthy rabbits. Thereafter, samples were stored 
at -80°C until further analysis (Figure 1). The study was approved by the KU Leuven Ethical 
Review Board for Animal Research and all animals were treated according to the Principles 
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of Laboratory Animal Care (US National Society for Medical Research) and the Guide for the 
Care and Use of Laboratory Animals (National Institutes of Health). 
Quantification of serum and liver bile acids levels: Individual serum bile acids were 
quantified by high performance liquid chromatography-mass spectrometry using authentic 
bile acid standards and deuterated internal standards. Serum samples (50 μL) were diluted 
with 50 μL of methanol containing 20.5 ng of deuterated internal standard (cholic acid). The 
samples were vortexed for 30 seconds, followed by centrifugation at 10,000 rpm for 10 
minutes. 150 µL of the supernatant was transferred to a clean Eppendorf tube and dried under 
nitrogen gas. Samples were reconstituted in 100 µL of the assay mobile phase. Typical 
recoveries of extracted bile acids exceeded 85%. Chromatographic separations were carried 
out with a Waters 2695 pump equipped with an autoinjector. The analytes were separated on a 
Phenomenex Synergi 4μ Hydro-RP 80Å. The mobile phase consisted of solvent A (water), 
solvent B (methanol), and solvent C (100 mm ammonium acetate, pH 4.5) delivered as a 
gradient: 0–5 min for solvent B, 55%; 5-15 min for solvent B, 55-75%; 15-23 min for solvent 
B, 75-80% and 35-40 min for solvent B, 55% with 10% solvent C at a constant flow rate of 
0.2 mL/min. The high performance liquid chromatography was coupled with a Waters ZQ 
quadruple mass detector via an electrospray ionization interface operating in the negative ion 
mode. Quantitative determination of bile acids was performed by time scheduled single ion 
recordings using (M – H)- ions. We determined the optimal parameters for the mass 
spectrometer for bile acid detection as follows; capillary voltage 3 kV, cone voltage 40 V, 
extractor voltage 5 V, and RF lens 0.3 V. Source temperature was 100°C and desolvation 
temperature 300°C. Desolvation gas flow was set at 350 L/h and cone gas flow rate was 60 
L/h. The detection limit for individual bile acids was 10 to 50 nmol/L. Total serum and liver 
bile acid levels were measured enzymatically using a bile acid assay kit in accordance with 
manufacturer’s protocol (Diazyme, Germany). Liver tissue was weighed and homogenized in 
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75% ethanol and incubated at 50°C for 2h to extract bile acids and centrifuged at 6000g for 
10min at 4°C. The bile acid content of the supernatant was determined and normalized with 
tissue weight used. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
were measured by an automated assay using Modular Roche and specific reagents 
(Roche/Hitachi, Bern, Switzerland). 
Cloning of rabbit genes of bile salt transporters and nuclear receptors: For OATP1, OATP8, 
MRP4, MDR3, CAR (NR1I3), and RXRA (NR2B1) mRNA sequences were not available. 
Therefore, total RNA was isolated from rabbit liver tissue using Qiazollysis reagent (Qiagen, 
Maryland, USA) and subsequently purified using the RNeasy mini RNA isolation kit 
(Qiagen).cDNA was obtained by reverse transcription of 1 µg total RNA with Super Script III 
Reverse Transcriptase (Invitrogen) using random hexamer primers (Invitrogen).Partial coding 
sequences were synthesized by a PCR procedure using oligonucleotides designed by 
comparing homology of published sequences from other species. When possible, 
oligonucleotides surrounded the start and stop codon. Missing 3’ ends were cloned by RACE 
procedure. The amplified fragments were cloned into the pGEM-T vector (Promega) followed 
by sequence analysis (LGC, Germany). These sequences showed high amino acid identity 
with the corresponding genes from other mammalian species and data have been submitted to 
the GenBank database (listed in Supl Table 1). Based upon these sequences, specific primers 
and probes for real-time PCR analysis were designed using Primer Express software 3.0 
(Applied Biosystems, Foster City, CA) and subsequently customized (Eurogentec, Seraing, 
Belgium). 
RNA isolation and real-time PCR: Total RNA was isolated as described above. All liver 
samples were reverse transcribed simultaneously. Reactions lacking reverse transcriptase 
were also run as a control for genomic DNA contamination. mRNA levels were quantified in 
fast real-time PCR with the StepOnePlus platform (Applied Biosystems, Lennik, Belgium) 
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using TaqMan chemistry for accurate quantification of mRNA levels. Sequences of the 
primers and probes are listed in Supplemental Table 1. The10 µL real time reaction mixture 
contained 5 µLTaqMan Fast Universal PCRMaster Mix (Applied Biosystems, Foster City, 
CA), 0.5 µL forward primer,0.5 µL reverse primer, 0.5 µLTaqMan probe ([5’]6-
FAM[3’]BHQ-1 labeled), 0.5 µL water, and 3µLcDNA(7.5 ng). Final concentrations were 
900 nM for the primers and 300 nM for the probes. Unknown samples were run in duplicate 
and individual samples with a CT value standard deviation greater than 0.3 were reanalyzed. 
Gene expression of ribosomal protein S18 (RPS18) remained stable in all study groups and 
was therefore used as an internal control. Data are expressed as a fold increase of the mean of 
the fed group. 
Immunoblot analysis: Fifty mg of frozen liver tissue was homogenized with a Precellys 24 
machine using ceramic beads (Bertin technologies, Montigny-le-Bretonneux, France) in lysis 
buffer containing phosphatase inhibitors (Halt Phosphatase Inhibitors Cocktail, Thermo 
Scientific, Aalst, Belgium). The protein content in the homogenate was determined by the 
Coomassie Protein Assay Reagent (Thermo Fisher Scientific, Aalst, Belgium). Equal amounts 
of homogenate proteins (20 µg) were separated by denaturing SDS gel electrophoresis in 10% 
Bis-Trisor 3-8% tris-acetate polyacrylamide gels (Bio-Rad Laboratories, Nazareth, Belgium) 
and separated proteins transferred to nitrocellulose membranes (Hybond, Ammersham 
Biosciences). Membranes were incubated overnight at 4°C with primary antibody and HRP-
linked secondary antibody for 1 hour at room temperature. Further information on the source 
and dilutions of the primary antibodies for MRP3, MRP4, CYP7A1, CK18 (Abcam, 
Cambridge, UK), BSEP (Santa Cruz Biotechnology, Santa Cruz, USA), MRP2, and 
secondary antibodies (DAKO, Denmark) are listed in Supplemental Table 2. For NTCP, 
OATP1, OATP8, OSTα, MDR1, and MDR3 no commercially available anti-rabbit antibodies 
were found. Immunoblots were developed using enhanced chemiluminescence technology 
9 
 
(PerkinElmer, Vilvoorde, Belgium) and analysed using ImageMaster Software 1D Elite (GE 
Healthcare Europe GmbH, Diegem, Belgium). Data were normalized for cytokeratin 18 
(CK18) as a loading control. 
Statistical analysis: Statistical analysis was performed using Statview 5.0.1 (SAS Institute, 
Cary, NC). All quantitative values were assessed for normality. Data were presented as mean 
 SEM or medians with IQR (1st-3rd) when appropriate. Paired measurements of the 
circulating bile acids were analyzed with Wilcoxon Signed Rank tests. Differences among 
study groups were analyzed by unpaired t-tests for normally distributed data and by Mann-
Whitney U tests for non-normally distributed data. Correlations were calculated using Pearson 
tests. For all tests a p-value less than 0.05 was deemed significant. 
 
Results 
Circulating levels of ALT, AST and bile acids 
After 7 days of critical illness, serum levels of the AST and ALT were lower in fasted 
compared to PN-fed critically ill rabbits (Figure 2). In contrast, the levels of total bile acids in 
the serum were not different between PN-fed and fasted critically ill rabbits (Figure 2). 
However, critical illness induced a shift in the composition of the circulating bile acid pool 
(Figure 3). In rabbits, unconjugated cholic acid (CA), deoxycholic acid (DCA), lithocholic 
acid (LCA) and hyodeoxycholic acid (HDCA) are the main circulating bile acids. If 
conjugated, they are predominantly glycine-bound. Median healthy baseline levels of CA 
were 0.14 µM (IQR 0.07 – 0.36), of DCA were 7.59 µM (IQR 3.62 – 18.52), of LCA were 
0.38 µM (IQR 0.18 - 0.78), of HDCA were 2.76 µM (IQR 1.63 – 4.48), of G-CA were 0.16 
(IQR 0.05 – 0.21) and of G-DCA were 0.34 (IQR 0.12 – 0.86). Compared to baseline values, 
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PN-fed rabbits displayed lower unconjugated CA and DCA levels, whereas in fasted rabbits 
only unconjugated DCA levels were not altered. Unconjugated LCA was increased 
comparably in both PN-fed and fasted critically ill rabbits, whereas HDCA was unaffected by 
critical illness. In contrast, conjugated glyco-deoxycholic acid (G-DCA) was increased in 
fasted critically ill rabbits, but not in PN-fed rabbits. This shift from unconjugated to 
conjugated bile acids in fasted animals was reflected in a 10- to 15-fold increase of the G-
CA/CA ratio and G-DCA/DCA ratio in fasted rabbits. PN-fed rabbits displayed a 3-fold 
increase in the G-CA/CA ratio (Figure 3). 
 
Bile acid synthesis enzymes and hepatobiliary transporters  
Hepatic protein levels of CYP7A1, the rate limiting enzyme in the bile acid synthesis, were 
not different between TPN-fed and fasted critically ill rabbits (Figure 2). Protein levels 
correlated well with mRNA levels of CYP7A1 (r=0.515; p=0.02). No correlation between the 
serum levels of total bile acids and hepatic mRNA or protein CYP7A1 levels was observed. 
Hepatic protein levels of the basolateral bile acid efflux transporters MRP3 and MRP4 were 
significantly higher in fasted compared with PN-fed critically ill rabbits (Figure 4). MRP3 and 
protein levels correlated inversely with mRNA levels (r=-0.553, p=0.009) and MRP4 protein 
levels did not correlate with mRNA levels. Gene expression of OSTα was not altered (Supl. 
Figure 1). 
We could not quantify protein levels of the basolateral uptake transporters NTCP, OATP1 and 
OATP8, but mRNA levels of NTCP (p=0.0003) and OATP8 (p=0.002) were lower in fasted 
compared with PN-fed critically ill rabbits (Supl. Figure 1). 
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Hepatic protein levels of the canalicular efflux pump MRP2 were lower in fasted compared 
with PN-fed critically ill rabbits (Figure 4). MRP2 protein levels correlated positively with 
MRP2 mRNA levels (r=0.871 p<0.0001). In contrast, the canalicular efflux pump BSEP 
protein levels were higher in fasted compared with PN-fed critically ill rabbits. However, 
BSEP protein levels did not correlate with BSEP mRNA levels. We could not quantify protein 
levels of the canalicular efflux pumps MDR1 and MDR3, but gene expression levels were 
lower in fasted compared with TPN-fed critically ill rabbits (p=0.0007 for MDR1, p=0.0004 
for MDR3, Supl. Figure 1). 
 
Nuclear receptors 
To identify the upstream regulators of the transporter expression levels, we quantified gene 
expression of the key regulating nuclear receptors. In normal physiological conditions 
farnesoid X receptor (FXR) is the predominant bile acid sensor, but also retinoid X receptor 
alpha (RXRA), the vitamin D receptor (VDR), pregnane X receptor and constitutive 
androstane receptor (CAR) are involved in the regulation of BA metabolism and/or transport 
[12].  
Gene expression levels of the nuclear receptors FXR and CAR were significantly lower in 
fasted compared with PN-fed critically ill rabbits (Figure 5). mRNA levels of FXR correlated 
inversely with the protein levels of the basolateral efflux pumps MRP3 and MRP4 and 
positively with the protein levels of the canalicular efflux pump MRP2 (Figure 5). Gene 
expression of the nuclear receptor RXRA was higher in fasted compared with PN-fed 
critically ill rabbits and correlated positively with MRP3 protein levels (Figure 5). Gene 
expression of the nuclear receptors PXR and VDR did not differ between the 2 study groups. 
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Discussion 
This study in a rabbit model of prolonged critical illness found that fasting by withholding PN 
reduced markers of hepatocellular injury and induced a shift towards more conjugated and 
less toxic bile acids. Fasting during critical illness was also associated with an increased 
protein expression of the bile acid efflux transporters at the basolateral (MRP3) and apical 
(BSEP) membranes. The increased expression of MRP3 was strongly associated with 
suppression of FXR.  
Fasting during prolonged critical illness in rabbits resulted in decreased levels of AST and 
ALT, indicating suppressed parenchymal damage. Parenchymal liver damage during critical 
illness, also called hypoxic liver injury [13], is associated with poor outcome in the ICU [14]. 
This is in contrast with the findings from a randomized controlled trial in adult critically ill 
patients [15]. Here, withholding PN during the first week of critical illness did not affect the 
number of patients with a clinically important increase in levels of AST and ALT. 
Surprisingly, fasting by withholding PN resulted in a higher proportion of patients with 
hyperbilirubinemia during the first week of critical illness. In the critically ill rabbits we could 
not detect bilirubin in the serum, neither by the conventional enzymatic essays nor by High 
Performance Liquid Chromatography. For this reason we focused on the bile acids as markers 
of cholestasis. Withholding PN did not affect the concentration of total bile acids in the serum 
or in the liver. Nevertheless, fasting induced a shift towards more conjugated bile acids. This 
indicates a protective response as conjugated bile acids are less toxic than their unconjugated 
counterparts. In critically patients the unconjugated bile acids, cholic acid and 
chenodeoxycholic acid, did not differ from controls, but went together with a large increase in 
the concentration of conjugated bile acids [6]. Similarly, the change in bile acid concentration 
could not be explained by increased de novo bile acid synthesis as the protein expression level 
of CYP7A1 was unaltered [6].  
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Hence, changes in the transport of the bile acids between the hepatocyte, the sinusoidal blood 
compartment and the canalicular bile compartment are most likely controlling the altered bile 
acid composition during critical illness. The strong upregulation of the basolateral efflux 
transporters MRP3 and MRP4 by fasting is striking. Under normal conditions these 
transporters exhibit only low expression levels in hepatocytes. Prolonged critical illness [6], 
inflammation [16] and longstanding cholestasis [17] have been associated with increased 
MRP3 and MRP4 expression. It is presumed that that the basolateral efflux transporters 
reverse the transport of primarily conjugated bile acids from the canalicular bile compartment 
to the blood for subsequent renal elimination. The observations that withholding PN reduced 
markers of hepatocellular injury in combination with increased MRP3 and MRP4 expression 
suggests that MRP3/4 upregulation is a protective response, at least from the standpoint of the 
liver. Whether the increased levels of bile acids and bilirubin, and the shift towards more 
conjugated bile acids in critically ill patients [6] and animals [18] holds a survival benefit is 
not clear. It suggests that the association between the increase of bilirubin levels during the 
first 48 hours after ICU admission and the risk of mortality described in an observational 
study [1] may not be causal. However, in other studies serum bilirubin levels were found to be 
a poor discriminator of increased mortality risk during critical illness [19;20].  
In observational studies during critical illness, artificial nutrition has been associated with the 
development of liver dysfunction [21;22]. The EPaNIC randomized controlled trial 
demonstrated that withholding PN lead to fewer patients with a clinically important increase 
in levels of GGT and ALP during the entire ICU stay, suggesting less cholestatic liver 
dysfunction [15]. Nevertheless, the proportion of patients with hyperbilirubinemia was higher 
in the late PN group. As this patients group had a shortened ICU stay, less new infections in 
the ICU and a faster recovery from organ failure, one can question whether 
hyperbilirubinemia alone is an appropriate marker of poor ICU outcome.  
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The metabolism and transport of the bile acids is tightly regulated by a complex network of 
nuclear receptors, of which FXR is the most important. Critical illness leads to decreased 
levels of FXR and its heterodimeric partner RXRA in the nucleus of the hepatocytes [6]. 
Fasting during critical may lead to a further decrease in the levels FXR. However, the gene 
expression levels of RXRA were increased by withholding PN in this rabbit study of critical 
illness. As we previously described discrepant responses between the gene and protein 
expression level, interpretation of the data should be done with caution [6]. However, taken 
that withholding PN during critical illness holds a beneficial response, reduced expression of 
the bile acid sensor FXR, maintenance of bile acid synthesis (CYP7A1) and reversal of bile 
acid transport (MRP3) may constitute a protective response. Indeed, previous studies in bile 
duct ligated mice have demonstrated that genetic abrogation of Fxr reduces liver injury and 
improves survival, accompanied by strong upregulation of the basolateral BA efflux 
transporter Mrp4 [23;24], a direct parallel of what was observed in the present study. This 
suggests that FXR antagonists may be therapeutically useful across a ranges of conditions 
where bile acids contribute to liver injury. 
Alternatively, the changes in bile acid metabolism and transport may reflect a dysfunctional 
feedback system and may herald poor outcome [20]. Starvation in non-critical care conditions 
gives rise to exacerbated liver apoptosis in FXR knock-out mice [25]. 
This study has some limitations. First, extrapolation from an animal model of critical illness 
to the human context is difficult. This was further complicated by the difficulty encountered 
in measuring bilirubin levels and protein levels of the basolateral bile acid transporters OATP 
and NTCP. Secondly, although animals were randomized into two groups, the association 
between the bile acids, their transporters and the regulating nuclear receptors cannot delineate 
causality. Future studies in which those components of bile acid regulation are manipulated 
by overexpression and knock-out models could provide additional mechanistic insight. 
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Thirdly, sham-operated, pair-fed animals were not added to the study. This was done as the 
key question was the impact of parenteral nutrition versus nutrient restriction during critical 
illness. 
In conclusion, during prolonged critical illness, withholding PN improved markers for 
hepatocellular injury in association with the reversal of normal bile acid trafficking and 
increased bile acid detoxification though conjugation. This suggests that fasting in critical 
illness induces adaptive changes in bile acid homeostasis, changes that could possibly be 
emulated by therapeutic interventions targeting FXR [12;26]. 
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FIGURE LEGENDS 
Figure 1: Schematic overview of the study protocol. 
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Figure 2: Serum TBA, ALT and AST and liver TBA and CYP7A1 in PN-fed and fasted 
prolonged critically ill rabbits. 
 
TBA serum shows day 7 circulating total bile acid concentration, ALT and AST AUC is the 
area under the curve using daily measurements, TBA liver and CYP7A1 shows the day 7 
values quantified in liver homogenates. Median healthy baseline levels were 13.0 µM (IQR 
7.5-18.9) for TBA, 41 U/L (IQR 31-61) for AST, and 30 U/L (IQR 18-61) for ALT. Levels 
are expressed as median with IQR (25th-75th percentiles). Abbreviations: TBA, total bile 
acids; AUC, area under the curve; OD, optical density. 
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Figure 3: Circulating bile acid concentrations in TPN-fed and fasted critically ill rabbits. 
 
Bile acids were determined by mass spectrometry at baseline (BL) and day 7 (d7) after onset 
of the illness and are expressed as the delta change from baseline. Levels are expressed in µM 
and are represented as median with IQR. * represents p≤0.05 for comparison of changes over 
time (baseline levels versus day 7 levels) using the Wilcoxon Signed Rank test. The p-values 
depicted on each panel were calculated using the nonparameteric Mann-Whitney U test for 
comparison of the differences over time between the fed and the fasted animals. 
Abbreviations:CA, cholic acid; DCA, deoxycholic acid; LCA, lithocholic acid; HDCA, 
hyodeoxycholic acid; G-CA, glycocholic acid; G-DCA, glycodeoxycholic acid. 
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Figure 4: Protein levels of hepatobiliary transporters in PN-fed and fasted prolonged 
critically ill rabbits. 
 
Hepatic basolateral efflux transporters (MRP3, MRP4), and canalicular efflux pumps (BSEP, 
MRP2) were quantified by Western blot using liver homogenates. Data are represented as 
median with IQR (25th-75th percentiles). Abbreviations: MRP, multidrug resistance-
associated protein; BSEP, bile salt export pump, OD optical density. 
 
Figure 5: (A) Gene expression levels of nuclear receptors in PN-fed and fasted prolonged 
critically ill rabbits. (B) Correlations between nuclear receptors and hepatobiliary 
transporters. 
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Data in (A) are represented as median with IQR (25th-75th percentiles). Abbreviations: FXR, 
farnesoid X receptor; VDR, vitamin D receptor; CAR, constitutive androstane receptor; PXR, 
pregnaneX receptor; RXRA, retinoid X receptor alpha. AU, arbitrary units, MRP multidrug 
resistance related protein. 
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